Quinazoline derivatives useful as anti-tumor medicament

Details Quinazoline derivatives useful as anti-tumor medicament Quinazoline derivatives useful as anti-tumor medicament

2006-10-20

2011-10-25

Wilson, James O (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S283000

Reexamination Certificate

active

08044063

ABSTRACT:
The present invention relates to quinazoline derivatives of the formula (I) useful as anti-tumor medicaments, or a pharmaceutically acceptable salt thereof, the definition of the substituents R1, R1′, R2, R2′ are as defined in the description. It also relates to a pharmaceutical composition containing same, and a method for the preparation of quinazoline derivatives of formula (I) or a pharmaceutically acceptable salt thereof.

REFERENCES:
patent: 1100046 (2003-01-01), None
patent: 0 520 722 (1992-12-01), None
patent: 0 566 226 (1993-10-01), None
patent: 0 635 498 (1995-01-01), None
patent: WO 96/09294 (1996-03-01), None
patent: WO 96/15118 (1996-05-01), None
patent: WO 96/30347 (1996-10-01), None
patent: WO 96/33980 (1996-10-01), None
patent: WO 97/30034 (1997-08-01), None
patent: WO 97/38983 (1997-10-01), None
patent: WO 99/06378 (1999-02-01), None
patent: WO 99/35146 (1999-07-01), None
patent: WO 00/06555 (2000-02-01), None
patent: WO 01/04111 (2001-01-01), None
patent: WO 01/21594 (2001-03-01), None
patent: WO 01/21596 (2001-03-01), None
patent: WO 01/32155 (2001-05-01), None
patent: WO 20O5/046678 (2005-05-01), None
patent: WO 2005/040125 (2005-05-01), None
patent: WO 2006/071017 (2006-07-01), None
patent: WO 2006/090717 (2006-08-01), None
Jordan, V. C. Nature Reviews: Drug Discovery, 2, 2003, 205.
Vippagunta, et al. Advanced Drug Delivery Reviews, 48, 2001, 18.
Blackledge G. et al., “Anti-EGF Receptor Therapy”,Prostate Cancer and Prostatic Diseases3(4):296-302 (2000).
Baselga J. et al., “ZD1839 (‘Iressa’)1,2as an Anticancer Agent”,Drugs 60, suppl. 1:33-40 (2000).
Denny W.A., “The 4-Anilinoquinazoline Class of Inhibitors of theerbB Family of Receptor Tyrosine Kinases”,IL Farmaco56:51-56 (2001).
Brignola P.S. et al., “Comparison of the Biochemical and Kinetic Properties of the Type 1 Receptor Tyrosine Kinase Intracellular Domains”,The Journal of Biological Chemistry277(2):1576-1585 (2002), XP-002531671.

Affiliated with

Also associated with

Rating

Quinazoline derivatives useful as anti-tumor medicament does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinazoline derivatives useful as anti-tumor medicament, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazoline derivatives useful as anti-tumor medicament will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4282484